Caplin Point Laboratories Ltd vs Cipla Ltd
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Caplin Point Laboratories Ltd currently has the stronger revenue growth signal.
Caplin Point Laboratories Ltd and Cipla Ltd show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Caplin Point Laboratories Ltd | Cipla Ltd |
|---|---|---|
| Current Price | ₹2,301.3 | ₹1,325.1 |
| Market Cap | ₹17,491.05 Cr. | ₹1.07 L Cr. |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| P/E Ratio | 26.28 | 29.9 |
| ROE (%) | 20.87 | 11.6 |
| Debt/Equity | 0.07 | 0.02 |
| Sales Growth 5Y (%) | 15.56 | 8.01 |
| Profit Growth 5Y (%) | 63.42 | 11.78 |
| Promoter Holding (%) | 70.57 | 29.22 |
| Revenue Rank | Rank 2 | Rank 3 |
| Margin Rank | Rank 3 | Rank 2 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No | No information |